Skip to Main Content

Paper Details

Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy.
Eur Urol
2
2018
Author NameAffiliation
Amirali SalmasiInstitute of Urologic Oncology, David Geffen School of Medicine at University of California los angeles
Izak FaienaInstitute of Urologic Oncology, David Geffen School of Medicine at University of California los angeles
Alexandra DrakakiInstitute of Urologic Oncology, David Geffen School of Medicine at University of California los angeles
  • 1 - 3

Datasets